182 related articles for article (PubMed ID: 36631604)
1. Effects of periodontal pathogen-induced intestinal dysbiosis on transplant immunity in an allogenic skin graft model.
Mei T; Noguchi H; Kuraji R; Kubo S; Sato Y; Kaku K; Okabe Y; Onishi H; Nakamura M
Sci Rep; 2023 Jan; 13(1):544. PubMed ID: 36631604
[TBL] [Abstract][Full Text] [Related]
2. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model.
Kashiwagi Y; Aburaya S; Sugiyama N; Narukawa Y; Sakamoto Y; Takahashi M; Uemura H; Yamashita R; Tominaga S; Hayashi S; Nozaki T; Yamada S; Izumi Y; Kashiwagi A; Bamba T; Ishihama Y; Murakami S
Sci Rep; 2021 Sep; 11(1):18398. PubMed ID: 34526589
[TBL] [Abstract][Full Text] [Related]
4. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.
Hamamoto Y; Ouhara K; Munenaga S; Shoji M; Ozawa T; Hisatsune J; Kado I; Kajiya M; Matsuda S; Kawai T; Mizuno N; Fujita T; Hirata S; Tanimoto K; Nakayama K; Kishi H; Sugiyama E; Kurihara H
Arthritis Res Ther; 2020 Oct; 22(1):249. PubMed ID: 33076980
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4
Sohn J; Li L; Zhang L; Settem RP; Honma K; Sharma A; Falkner KL; Novak JM; Sun Y; Kirkwood KL
Mol Oral Microbiol; 2022 Apr; 37(2):42-52. PubMed ID: 34958712
[TBL] [Abstract][Full Text] [Related]
6. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
Simas AM; Kramer CD; Weinberg EO; Genco CA
Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
[TBL] [Abstract][Full Text] [Related]
7. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
[TBL] [Abstract][Full Text] [Related]
8. Oral bacteria affect the gut microbiome and intestinal immunity.
Kobayashi R; Ogawa Y; Hashizume-Takizawa T; Kurita-Ochiai T
Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32504490
[TBL] [Abstract][Full Text] [Related]
9. Periodontitis induced by
Blasco-Baque V; Garidou L; Pomié C; Escoula Q; Loubieres P; Le Gall-David S; Lemaitre M; Nicolas S; Klopp P; Waget A; Azalbert V; Colom A; Bonnaure-Mallet M; Kemoun P; Serino M; Burcelin R
Gut; 2017 May; 66(5):872-885. PubMed ID: 26838600
[TBL] [Abstract][Full Text] [Related]
10. Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis.
Sugiyama N; Uehara O; Morikawa T; Paudel D; Ebata K; Hiraki D; Harada F; Yoshida K; Kato S; Nagasawa T; Miura H; Abiko Y; Furuichi Y
Odontology; 2022 Oct; 110(4):673-681. PubMed ID: 35333990
[TBL] [Abstract][Full Text] [Related]
11. Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis.
Park S; Kim I; Han SJ; Kwon S; Min EJ; Cho W; Koh H; Koo BN; Lee JS; Kwon JS; Seo KY; Ha JW; Park YM
J Clin Periodontol; 2023 Nov; 50(11):1553-1567. PubMed ID: 37621247
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.
Wu H; Singer J; Kwan TK; Loh YW; Wang C; Tan J; Li YJ; Lai SWC; Macia L; Alexander SI; Chadban SJ
J Am Soc Nephrol; 2020 Jul; 31(7):1445-1461. PubMed ID: 32482686
[TBL] [Abstract][Full Text] [Related]
13.
Chi L; Cheng X; Lin L; Yang T; Sun J; Feng Y; Liang F; Pei Z; Teng W
Front Cell Infect Microbiol; 2021; 11():755925. PubMed ID: 34926316
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota.
Watanabe K; Katagiri S; Takahashi H; Sasaki N; Maekawa S; Komazaki R; Hatasa M; Kitajima Y; Maruyama Y; Shiba T; Komatsu K; Ohsugi Y; Tanaka K; Matsuzawa A; Hirota T; Tohara H; Eguchi Y; Anzai K; Hattori A; Iwata T
FASEB J; 2021 Feb; 35(2):e21171. PubMed ID: 33197074
[TBL] [Abstract][Full Text] [Related]
15. A Potential Role of Phospholipase 2 Group IIA (PLA
Gonzalez OA; Euzebio-Alves V; Alimova Y; Al-Attar A; Ebersole JL
Adv Exp Med Biol; 2019; 1197():79-95. PubMed ID: 31732936
[TBL] [Abstract][Full Text] [Related]
16. Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake.
Gargari G; Deon V; Taverniti V; Gardana C; Denina M; Riso P; Guardamagna O; Guglielmetti S
FEMS Microbiol Ecol; 2018 May; 94(5):. PubMed ID: 29566154
[TBL] [Abstract][Full Text] [Related]
17. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
[TBL] [Abstract][Full Text] [Related]
18. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-Induced Gut Microbiota Dysbiosis Damages the Intestinal Barrier, Increasing Food Allergy in Adult Mice.
Zhang Q; Cheng L; Wang J; Hao M; Che H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684316
[TBL] [Abstract][Full Text] [Related]
20. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
